Don't want ads? Subscribe or login now.

Novo Nordisk Says Officials Not Qualified To Doubt Drug Bills

By Ben Adlin · October 21, 2025, 10:45 PM EDT

Attorneys for Novo Nordisk Inc. on Tuesday sought to undercut witness testimony that Medicaid claims in Washington state for the company's hemophilia drug NovoSeven were shockingly high, leading one state auditor...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Case Information

Case Title

Siegel v. Novo Nordisk Inc

Case Number

3:23-cv-05459

Court

Washington Western

Nature of Suit

Other Statutes: False Claims Act

Date Filed

May 18, 2023

Recent Articles By Ben

October 28, 2025
Off-Label Prescribing Was Common, Novo Nordisk Tells Jury
October 27, 2025
Whistleblower 'Horrified' By Novo Nordisk Drug Sales Tactics
October 22, 2025
Novo Nordisk Paid Patient Benefits, Not Bribes, Jury Hears
October 20, 2025
Novo Nordisk Trial Kicks Off Over Kickback Allegations
October 15, 2025
Wash. Panel Mulls Trimming $103M Ruling Against Nationwide
October 06, 2025
Seattle Law Firm Inks Insurance Deal In $1M Data Breach Suit
September 18, 2025
Wash. Panel Calls Gas Station Co.'s Insurance Delay Risky